Jean Claude Dusingize1,2, Catherine M Olsen1,3, Jiyuan An4, Nirmala Pandeya1,2, Matthew H Law4, Bridie S Thompson1, Alisa M Goldstein5, Mark M Iles6, Penelope M Webb1,2, Rachel E Neale1,2, Jue-Sheng Ong4, Stuart MacGregor3,4, David C Whiteman1,2. 1. Department of Population Health, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. 2. School of Public Health, University of Queensland, Brisbane, QLD, Australia. 3. School of Medicine, University of Queensland, Brisbane, QLD, Australia. 4. Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. 5. Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. 6. Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
Abstract
BACKGROUND: Height and body mass index (BMI) have both been positively associated with melanoma risk, although findings for BMI have been less consistent than height. It remains unclear, however, whether these associations reflect causality or are due to residual confounding by environmental and lifestyle risk factors. We re-evaluated these associations using a two-sample Mendelian randomization (MR) approach. METHODS: We identified single nucleotide polymorphisms (SNPs) for BMI and height from separate genome-wide association study (GWAS) meta-analyses. We obtained melanoma SNPs from the most recent melanoma GWAS meta-analysis comprising 12 874 cases and 23 203 controls. We used the inverse variance-weighted estimator to derive separate causal risk estimates across all SNP instruments for BMI and height. RESULTS: Based on the combined estimate derived from 730 SNPs for BMI, we found no evidence of an association between genetically predicted BMI and melanoma [odds ratio (OR) per one standard deviation (1 SD) (4.6 kg/m2) increase in BMI 1.00, 95% confidence interval (CI): 0.91-1.11]. In contrast, we observed a positive association between genetically-predicted height (derived from a pooled estimate of 3290 SNPs) and melanoma risk [OR 1.08, 95% CI: 1.02-1.13, per 1 SD (9.27 cm) increase in height]. Sensitivity analyses using two alternative MR methods yielded similar results. CONCLUSIONS: These findings provide no evidence for a causal association between higher BMI and melanoma, but support the notion that height is causally associated with melanoma risk. Mechanisms through which height influences melanoma risk remain unclear, and it remains possible that the effect could be mediated through diverse pathways including growth factors and even socioeconomic status.
BACKGROUND: Height and body mass index (BMI) have both been positively associated with melanoma risk, although findings for BMI have been less consistent than height. It remains unclear, however, whether these associations reflect causality or are due to residual confounding by environmental and lifestyle risk factors. We re-evaluated these associations using a two-sample Mendelian randomization (MR) approach. METHODS: We identified single nucleotide polymorphisms (SNPs) for BMI and height from separate genome-wide association study (GWAS) meta-analyses. We obtained melanoma SNPs from the most recent melanoma GWAS meta-analysis comprising 12 874 cases and 23 203 controls. We used the inverse variance-weighted estimator to derive separate causal risk estimates across all SNP instruments for BMI and height. RESULTS: Based on the combined estimate derived from 730 SNPs for BMI, we found no evidence of an association between genetically predicted BMI and melanoma [odds ratio (OR) per one standard deviation (1 SD) (4.6 kg/m2) increase in BMI 1.00, 95% confidence interval (CI): 0.91-1.11]. In contrast, we observed a positive association between genetically-predicted height (derived from a pooled estimate of 3290 SNPs) and melanoma risk [OR 1.08, 95% CI: 1.02-1.13, per 1 SD (9.27 cm) increase in height]. Sensitivity analyses using two alternative MR methods yielded similar results. CONCLUSIONS: These findings provide no evidence for a causal association between higher BMI and melanoma, but support the notion that height is causally associated with melanoma risk. Mechanisms through which height influences melanoma risk remain unclear, and it remains possible that the effect could be mediated through diverse pathways including growth factors and even socioeconomic status.
Authors: Aaron P Thrift; Jian Gong; Ulrike Peters; Jenny Chang-Claude; Anja Rudolph; Martha L Slattery; Andrew T Chan; Tonu Esko; Andrew R Wood; Jian Yang; Sailaja Vedantam; Stefan Gustafsson; Tune H Pers; John A Baron; Stéphane Bezieau; Sébastien Küry; Shuji Ogino; Sonja I Berndt; Graham Casey; Robert W Haile; Mengmeng Du; Tabitha A Harrison; Mark Thornquist; David J Duggan; Loic Le Marchand; Mathieu Lemire; Noralane M Lindor; Daniela Seminara; Mingyang Song; Stephen N Thibodeau; Michelle Cotterchio; Aung Ko Win; Mark A Jenkins; John L Hopper; Cornelia M Ulrich; John D Potter; Polly A Newcomb; Robert E Schoen; Michael Hoffmeister; Hermann Brenner; Emily White; Li Hsu; Peter T Campbell Journal: Int J Epidemiol Date: 2015-05-20 Impact factor: 7.196
Authors: Catherine M Olsen; Adèle C Green; Rachel E Neale; Penelope M Webb; Rebekah A Cicero; Lea M Jackman; Suzanne M O'Brien; Susan L Perry; Barbara A Ranieri; David C Whiteman Journal: Int J Epidemiol Date: 2012-08 Impact factor: 7.196
Authors: Elizabeth L Brandon; Jian-Wei Gu; Lauren Cantwell; Zhi He; Gray Wallace; John E Hall Journal: Cancer Biol Ther Date: 2009-10 Impact factor: 4.742
Authors: Ben Zhang; Xiao-Ou Shu; Ryan J Delahanty; Chenjie Zeng; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Joe Dennis; Wanqing Wen; Jirong Long; Chun Li; Alison M Dunning; Jenny Chang-Claude; Mitul Shah; Barbara J Perkins; Kamila Czene; Hatef Darabi; Mikael Eriksson; Stig E Bojesen; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Diether Lambrechts; Patrick Neven; Hans Wildiers; Giuseppe Floris; Marjanka K Schmidt; Matti A Rookus; Katja van den Hurk; Wim L A M de Kort; Fergus J Couch; Janet E Olson; Emily Hallberg; Celine Vachon; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Julian Peto; Isabel Dos-Santos-Silva; Olivia Fletcher; Nichola Johnson; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Jingmei Li; Keith Humphreys; Judith Brand; Pascal Guénel; Thérèse Truong; Emilie Cordina-Duverger; Florence Menegaux; Barbara Burwinkel; Frederik Marme; Rongxi Yang; Harald Surowy; Javier Benitez; M Pilar Zamora; Jose I A Perez; Angela Cox; Simon S Cross; Malcolm W R Reed; Irene L Andrulis; Julia A Knight; Gord Glendon; Sandrine Tchatchou; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Georgia Chenevix-Trench; Christopher A Haiman; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Annika Lindblom; Sara Margolin; Maartje J Hooning; John W M Martens; Madeleine M A Tilanus-Linthorst; J Margriet Collée; John L Hopper; Melissa C Southey; Helen Tsimiklis; Carmel Apicella; Susan Slager; Amanda E Toland; Christine B Ambrosone; Drakoulis Yannoukakos; Graham G Giles; Roger L Milne; Catriona McLean; Peter A Fasching; Lothar Haeberle; Arif B Ekici; Matthias W Beckmann; Hermann Brenner; Aida Karina Dieffenbach; Volker Arndt; Christa Stegmaier; Anthony J Swerdlow; Alan Ashworth; Nick Orr; Michael Jones; Jonine Figueroa; Montserrat Garcia-Closas; Louise Brinton; Jolanta Lissowska; Martine Dumont; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Hiltrud Brauch; Thomas Brüning; Yon-Dschun Ko; Paolo Peterlongo; Siranoush Manoukian; Bernardo Bonanni; Paolo Radice; Natalia Bogdanova; Natalia Antonenkova; Thilo Dörk; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Peter Devilee; Caroline Seynaeve; Christi J Van Asperen; Anna Jakubowska; Jan Lubiński; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Ute Hamann; Diana Torres; Rita K Schmutzler; Susan L Neuhausen; Hoda Anton-Culver; Vessela N Kristensen; Grethe I Grenaker Alnæs; Brandon L Pierce; Peter Kraft; Ulrike Peters; Sara Lindstrom; Daniela Seminara; Stephen Burgess; Habibul Ahsan; Alice S Whittemore; Esther M John; Marilie D Gammon; Kathleen E Malone; Daniel C Tessier; Daniel Vincent; Francois Bacot; Craig Luccarini; Caroline Baynes; Shahana Ahmed; Mel Maranian; Catherine S Healey; Anna González-Neira; Guillermo Pita; M Rosario Alonso; Nuria Álvarez; Daniel Herrero; Paul D P Pharoah; Jacques Simard; Per Hall; David J Hunter; Douglas F Easton; Wei Zheng Journal: J Natl Cancer Inst Date: 2015-08-20 Impact factor: 13.506
Authors: Jessica Tyrrell; Samuel E Jones; Robin Beaumont; Christina M Astley; Rebecca Lovell; Hanieh Yaghootkar; Marcus Tuke; Katherine S Ruth; Rachel M Freathy; Joel N Hirschhorn; Andrew R Wood; Anna Murray; Michael N Weedon; Timothy M Frayling Journal: BMJ Date: 2016-03-08
Authors: Andrea Weber; Michael F Leitzmann; Anja M Sedlmeier; Hansjörg Baurecht; Carmen Jochem; Sebastian Haferkamp; Sebastian E Baumeister Journal: Br J Cancer Date: 2021-05-31 Impact factor: 7.640
Authors: Mathew Vithayathil; Paul Carter; Siddhartha Kar; Amy M Mason; Stephen Burgess; Susanna C Larsson Journal: PLoS Med Date: 2021-07-29 Impact factor: 11.613